INSITE Trial included more than 400 patients at 14 leading academic and community cancer centers Intracavity visualization system uses fluorescence imaging designed to identify residual cancer and ...

The FDA approved pegulicianine (LumiSight) as an optical imaging agent for detecting residual cancer after breast-conserving surgery (BCS). The approval stipulates use of pegulicianine with the ...

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is ...

Clinical data from two ongoing trials in patients undergoing lumpectomy confirm strong safety profile and growing performance benefits of device Primary safety and secondary performance objectives met ...

Approval was supported by data from a randomized, intra-patient controlled trial, which included patients with confirmed invasive breast cancer, ductal carcinoma in situ, or both. The Food and Drug ...

Breast cancer death rates have been declining since 1989, but the disease remains the second leading cause of cancer death in women. And incidence rates have increased slightly in recent years. For ...

DOCTOR, MOST PEOPLE ASSOCIATE BREAST RECONSTRUCTION WITH THE SINGLE OR DOUBLE MASTECTOMY. BUT WHAT ABOUT A LUMPECTOMY, WHEN ONLY PART OF THE BREAST IS REMOVED? JOINING US LIVE THIS MORNING IS MERCY ...

In a clinical trial of 406 patients, Mass General Cancer Center investigators found that real-time imaging using a fluorescent agent had a favorable impact for 1 in 10 patients, with potential to ...

Breast cancer patients may benefit from undergoing a lumpectomy if they have two or three tumors, a new study conducted by the National Institute of Health found. According to The Hill, researchers ...

No surgery guidelines existed for these patients but some doctors already were offering lumpectomy as a choice, said Dr. Judy Boughey of Mayo Clinic, who led the research. "This will make them more ...

LumiSystem is the first and only fluorescence-guided imaging technology for breast cancer detection, enabling a more complete resection NEWTON, Mass., Jan. 27, 2025 /PRNewswire/ -- Lumicell, Inc., a ...